Evidence map›Paper›PMID 28791876›Full record

ArticleAIDS care2018

Limited awareness of pre-exposure prophylaxis among black men who have sex with men and transgender women in New York city.

Matthew Garnett, Yael Hirsch-Moverman, Julie Franks, Eleanor Hayes-Larson, Wafaa M El-Sadr, Sharon Mannheimer

Open access · greenAbstract read
In one paragraph

Article in AIDS care, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed, 1 pooled it
7.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 1 synthesis or guideline pooled it, 85 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Increased PrEP uptake and PrEP-RN coincide with decreased HIV diagnoses in men who have sex with men in Ottawa, Canada.Canada communicable disease report = Releve des maladies transmissibles au Canada · 2023
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Matthew Garnetta ICAP at Columbia University, Mailman School of Public Health , Columbia University , New York , NY , USA.ORCID http://orcid.org/0000-0002-1867-6856
Yael Hirsch-Movermana ICAP at Columbia University, Mailman School of Public Health , Columbia University , New York , NY , USA.ORCID http://orcid.org/0000-0003-0096-1306
Julie Franksa ICAP at Columbia University, Mailman School of Public Health , Columbia University , New York , NY , USA.ORCID http://orcid.org/0000-0001-6329-2301
Eleanor Hayes-Larsona ICAP at Columbia University, Mailman School of Public Health , Columbia University , New York , NY , USA.
Wafaa M El-Sadra ICAP at Columbia University, Mailman School of Public Health , Columbia University , New York , NY , USA.ORCID http://orcid.org/0000-0003-3735-9781
Sharon Mannheimera ICAP at Columbia University, Mailman School of Public Health , Columbia University , New York , NY , USA.
Columbia University · USHarlem Hospital Center · US

Funding

Global HIV Implementation Science Research Training Grant RenewalT32AI114398 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Yael R Hirsch-Moverman · 2014 to 2026
$4.1M
STAR-Seek, Test and Retain. Linkages for Black HIV+, Substance Using MSMR01DA032100 · NIDA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI EL-SADR, WAFAA M., MANNHEIMER, SHARON B · 2011 to 2015
$2.7M
Preventing Childhood Tuberculosis in Lesotho (PREVENT Study)K01AI104351 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI HIRSCH-MOVERMAN, YAEL R · 2014 to 2018
$635k
NIAID NIH HHS K01 AI104351NIAID NIH HHS T32 AI114398NIDA NIH HHS R01 DA032100
6 · The paper itself

Abstract

Awareness of Pre-exposure prophylaxis (PrEP) was assessed among a cohort of substance-using black men who have sex with men and transgender women (MSM/TGW) participating in the STAR Study, which recruited black MSM/TGW in New York City for HIV testing and linked HIV-infected individuals into care from July 2012 to April 2015. Sociodemographic, psychosocial, known HIV risk factors, and PrEP awareness were assessed among participants. Multivariable logistic regression was conducted to assess factors associated with PrEP awareness. Of 1673 participants, median age was 43 years and 25% were under age 30. Most participants (85.8%) reported having insufficient income for basic necessities at least occasionally, 54.8% were homeless, and 71.3% were unemployed. Awareness of PrEP was reported among 18.2% of participants. PrEP awareness was associated with younger age (adjusted odds ratio [aOR] 0.87, per 5 years), gay identity (aOR 2.46), higher education (aOR 1.70), more frequent past HIV testing (aOR 3.18), less HIV stigma (aOR 0.61), less hazardous/harmful alcohol use (aOR 0.61), and more sexual partners (aOR 1.04, per additional partner in past 30 days). In this substance-using black MSM/TGW cohort with high rates of poverty and homelessness, PrEP awareness was low. This study demonstrates the need for targeted dissemination of PrEP information to key populations to increase awareness and ultimately improve uptake and utilization of PrEP.

Indexed as

Health Knowledge, Attitudes, PracticePre-Exposure ProphylaxisTransgender PersonsAdolescentAdultAwarenessBlack or African AmericanCross-Sectional StudiesFemaleHIV InfectionsHomosexuality, MaleHumansLogistic ModelsMaleMiddle AgedNew York CityHIV preventionmen who have sex with men (MSM)pre-exposure prophylaxis (PrEP)transgender women (TGW)

Identifiers

PMID28791876
PMCPMC5699928
OpenAlexW2744831443

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.